Advanced Breast Cancer
Watch interviews and expert perspectives covering the latest findings for treating HR+/HER2 Advanced Breast Cancer using CDK4/6 inhibitors from key cancer congresses throughout 2019.
CME activities are developed by touchIME for touchONCOLOGY.
Our education resources are developed in collaboration with our well established peer-reviewed medical journals, our Editorial Board members and partnerships with major medical societies, with a clear commitment to high-quality independent education.